Beranda › Kanker (semua jenis) › California › Los Angeles
Uji klinis Kanker (semua jenis) di Los Angeles, CA
74 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Los Angeles (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Menerima pesertaFase 3
- Keck Medicine of USC, Los Angeles
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 2/3
- USC Norris Comprehensive Cancer Center /ID# 275343, Los Angeles
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Menerima pesertaFase 2
- Start Los Angeles /ID# 281533, Los Angeles
A Study of PHN-012 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- PHN-012-001 Site, Los Angeles
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Menerima pesertaFase 1/2
- Children's Hospital Los Angeles ( Site 4006), Los Angeles
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Menerima pesertaFase 2/3
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Menerima pesertaFase 3
- The Angeles Clinic and Research Institute, West Los Angeles Office, Los Angeles
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Menerima pesertaFase 3
- Quetzal Site 7, Los Angeles
Intratumoral N17350 in Advanced Solid Tumors
Menerima pesertaFase 1/2
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Menerima pesertaFase 2
- The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Menerima pesertaFase 1/2
- Childrens Hospital Los Angeles ( Site 3006), Los Angeles
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Menerima pesertaFase 2
- UCLA Medical Center, Los Angeles
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Menerima pesertaFase 1/2
- University of Southern California /ID# 272414, Los Angeles
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Menerima pesertaFase 1/2
- University of Southern California Norris Comprehensive, Los Angeles
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Menerima pesertaFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Menerima pesertaFase 1/2
- California Research Institute, Los Angeles
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Cedars-Sinai Medical Center, Los Angeles
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Menerima pesertaStudi observasional
- USC/Norris Comprehensive Cancer Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Menerima pesertaFase 3
- Los Angeles Cancer Network, Los Angeles
- Cedars-Sinai Cancer at Cedars-Sinai Medical Facility, Los Angeles
- Los Angeles Cancer Network_Century City, Los Angeles
- dan 3 lainnya
Lurbinectedin in FET-Fused Tumors
Menerima pesertaFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- University of California, Los Angeles (Data or Specimen Analysis Only), Los Angeles
A Study of ARC-02 in B-cell NHL
Menerima pesertaFase 1
- Start Cala, Los Angeles
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Menerima pesertaFase 1
- UCLA, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
Effect of Meal Timing During Adjuvant Treatment for Cancer
Menerima peserta
- Cedars Sinai Medical Center (CSMC), Los Angeles
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Children's Hospital Los Angeles, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Mattel Children's Hospital UCLA, Los Angeles
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Menerima pesertaFase 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California Los Angeles, Los Angeles
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Menerima pesertaFase 1/2
- Site 03, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- University of California, Los Angeles (UCLA), Los Angeles
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
Menerima peserta
- Cedars-Sinai Medical Center, Los Angeles
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Menerima pesertaFase 1
- START Los Angeles, Los Angeles
International Rare Brain Tumor Registry
Menerima pesertaStudi observasional
- Children's Hospital Los Angeles, Los Angeles
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Menerima pesertaFase 2
- UCLA Medical Center, Los Angeles
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Kaiser Permanente West Los Angeles, Los Angeles
Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology
Menerima pesertaFase 2
- Cedars Sinai Medical Center, Los Angeles
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Menerima pesertaFase 2
- Children's Hospital Los Angeles, Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Menerima pesertaFase 1/2
- California Research Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
Menerima pesertaSukarelawan sehat diterima
- Children's Hospital Los Angeles, Los Angeles
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- The Angeles Clinic and Research Institute, Los Angeles
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Menerima pesertaFase 2
- USC Norris Comprehensive Cancer Center /ID# 274550, Los Angeles
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Ellison Clinic at Saint John's, Los Angeles
The STOP-MED CTRCD Trial
Menerima pesertaFase 4
- University of California, Los Angeles, Los Angeles
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Menerima pesertaFase 2
- UCLA Department of Medicine, Los Angeles
EXoPERT EMERALD Clinical Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- City of Hope Duarte Cancer Center, Los Angeles
Molecular Genetics Studies of Cancer Patients and Their Relatives
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Menerima pesertaFase 1
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
Childhood Cancer Survivor Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Children's Hospital Los Angeles, Los Angeles
- University of California-Los Angeles, Los Angeles
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- UCLA Medical Center, Los Angeles
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Menerima pesertaFase 1/2
- The Angeles Clinic and Research Institute, Los Angeles
LIFE Cancer Survivorship Database for Pediatric Cancer
Menerima pesertaStudi observasional
- Children's Hospital Los Angeles, Los Angeles
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
Menerima pesertaSukarelawan sehat diterima
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Menerima pesertaFase 2
- University of Southern California, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Menerima peserta
- Oncology Institute for Hope and Innovation, Los Angeles
Norris ORIEN Total Cancer Care
Menerima pesertaStudi observasional
- USC / Norris Comprehensive Cancer Center, Los Angeles
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
Menerima pesertaFase 1/2
- Los Angeles General Medical Center, Los Angeles
- USC/Norris Comprehensive Cancer Center, Los Angeles
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- UCLA, Los Angeles
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Menerima pesertaStudi observasional
- Jonsson Comprehensive Cancer Center, Los Angeles
eMOTION: Examining Implicit Attitudes in Physical Activity Engagement
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Univeristy of Southern California, Los Angeles
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Menerima pesertaFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- UCLA Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
Menerima pesertaFase 1
- University of Southern California, Los Angeles
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
Menerima peserta
- Cedars-Sinai Medical Center (CSMC), Los Angeles
- University of California Los Angeles, Los Angeles
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
Menerima pesertaSukarelawan sehat diterima
- Children's Hospital Los Angeles, Los Angeles
eMOTION: Examining Affective Mechanisms in Physical Activity Engagement
Menerima pesertaSukarelawan sehat diterima
- University of Southern California, Los Angeles
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Menerima pesertaStudi observasional
- University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- UCLA Health, Los Angeles
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Menerima pesertaFase 1/2
- University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
Trial of DFP-14927 in Advanced Solid Tumors
Menerima pesertaFase 1
- UCLA Department of Medicine- Hematology/Oncology, Los Angeles
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Menerima pesertaFase 1/2
- The Angeles Clinic and Research Institute, Los Angeles
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- MiraKind, Los Angeles
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- Los Angeles General Medical Center, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
- dan 2 lainnya
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
Menerima pesertaFase 4
- VA Greater Los Angeles Healthcare System, Los Angeles
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY109 studi
- Boston, MA85 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Washington, DC58 studi
- Durham, NC58 studi
- Chicago, IL51 studi
- Atlanta, GA49 studi
- Seattle, WA49 studi
- Arlington, VA48 studi
- St. Louis, MO46 studi
Studi lain di Los Angeles
- Kanker Paru Non-Sel Kecil87 studi
- Kanker Payudara73 studi
- Kanker Prostat61 studi
- Kanker Kolorektal59 studi
- Kanker Metastatik57 studi
- Kanker Ovarium50 studi
- Kanker Paru45 studi
- Karsinoma Sel Skuamosa Kepala dan Leher42 studi
- Kanker Pankreas35 studi
- Kanker Endometrium34 studi
- Melanoma34 studi
- Kanker Payudara Triple-Negatif27 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.